Cipla Limited
Mumbai, India
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: Cipla Limited
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Mumbai, India
- Modalities
- Small Molecule (Oral Solid Dose), Sterile Injectables, Inhalation / MDI (Albuterol), API, Generics, Biosimilars (emerging)
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Cipla Limited
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule (Oral Solid Dose), Sterile Injectables, Inhalation / MDI (Albuterol), API, Generics, Biosimilars (emerging)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press8 articles
Broad modality coverage (6 modalities)
Recent News 8 articles
MedTherapy details India manufacturing plans for CAR-T and gene therapies - expresspharma.in
Cipla, Kemwell Ink Joint Venture Pact to Boost Global Biologics Play - Medical Dialogues
Cipla, Stempeutics launch stem cell therapy for knee osteoarthritis - Business Standard
Cipla partners with Stempeutics, launches Stem Cell Therapy for Knee Osteoarthritis - drugscontrol.org
Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences - Indian Pharma Post
Strategic Leadership Shift Cohance Lifesciences Appoints Umang Vohra as Executive Chairman and Group CEO - Telugu Times
Cohance Lifesciences appoints Umang Vohra as Executive Chairman, Group CEO - ET Manufacturing
MedTherapy Biotech to make India the global manufacturing hub for cancer gene therapy - Pharmabiz.com
Frequently Asked Questions About Cipla Limited
What is Cipla Limited's CDMO Signal Score?
Cipla Limited has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cipla Limited for a manufacturing program?
Use the free AI matchmaker to compare Cipla Limited against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Amneal Pharmaceuticals
Bridgewater, NJ
Small Molecule (Oral Solid Dose), Sterile Injectables, Biosimilars, Generic Drug Products, Blow-Fill-Seal (BFS), Ophthalmics, Inhalation (MDI/DPI)
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Aurobindo Pharma (Sterile Injectables Division)
Hyderabad, India
Sterile Injectables, Lyophilized Vials, Biologics (emerging), Small Molecule Injectable, Terminal Sterilization
Torrent Pharmaceuticals Limited
Ahmedabad, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Generic Drug Products, CDMO (via JB Pharma acquisition)
Dr. Reddy's Laboratories
Hyderabad, India
Small Molecule API, Generics, Biosimilars, Biologics (Drug Substance & Drug Product), Oligonucleotides, Steroids / Corticosteroids, Oncology / HPAPI, Sterile Injectables / Fill-Finish, Peptide API